T cell recognition of haptens, a molecular view.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 7524836)

Published in Int Arch Allergy Immunol on May 01, 1994

Authors

S Martin1, H U Weltzien

Author Affiliations

1: Max-Planck-Institut für Immunbiologie, Freiburg, BRD.

Articles citing this

T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest (2001) 1.90

Structural basis of chronic beryllium disease: linking allergic hypersensitivity and autoimmunity. Cell (2014) 1.55

Delayed drug hypersensitivity: models of T-cell stimulation. Br J Clin Pharmacol (2011) 1.29

Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity. J Exp Med (1999) 1.26

Idiosyncratic adverse drug reactions: current concepts. Pharmacol Rev (2013) 1.12

Immunostimulatory activity of haptenated proteins. Proc Natl Acad Sci U S A (2009) 1.10

Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine. J Clin Invest (1997) 0.92

Cross-talk between V beta 8+ and gamma delta+ T lymphocytes in contact sensitivity. Immunology (1998) 0.87

The murine buccal mucosa is an inductive site for priming class I-restricted CD8+ effector T cells in vivo. Clin Exp Immunol (1998) 0.84

4D-fingerprint categorical QSAR models for skin sensitization based on the classification of local lymph node assay measures. Chem Res Toxicol (2007) 0.84

Allergic reactions to drugs: involvement of T cells. Thorax (2000) 0.83

Major histocompatibility complex-independent recognition of a distinctive pollen antigen, most likely a carbohydrate, by human CD8+ alpha/beta T cells. J Exp Med (1997) 0.81

The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions. Immunogenetics (2017) 0.80

A tale of two pities: autologous melanoma vaccines on the brink. Hum Vaccin Immunother (2012) 0.78

Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation. J Immunol (2016) 0.77

Notes on the epidemiology of multiple sclerosis, with special reference to dietary habits. Int J Mol Sci (2014) 0.75

The T Cell Response to the Contact Sensitizer Paraphenylenediamine Is Characterized by a Polyclonal Diverse Repertoire of Antigen-Specific Receptors. Front Immunol (2017) 0.75

Articles by these authors

Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim Biophys Acta (1979) 2.35

The nature of the cilicin K receptor of Escherichia coli Cullen. J Exp Med (1971) 1.69

Dominance of one T-cell receptor in the H-2Kb/TNP response. Nature (1987) 1.63

Reactivity of V beta 17a+ CD8+ T cell hybrids. Analysis using a new CD8+ T cell fusion partner. J Exp Med (1989) 1.17

Aged murine killer T-cell clones acquire specific cytotoxicity for P815 mastocytoma cells. Nature (1984) 1.08

Characterization of processing requirements and metal cross-reactivities in T cell clones from patients with allergic contact dermatitis to nickel. Eur J Immunol (1995) 1.06

Preferential expression of a defined T-cell receptor beta-chain gene in hapten-specific cytotoxic T-cell clones. Nature (1986) 1.03

Dominance of the BV17 element in nickel-specific human T cell receptors relates to severity of contact sensitivity. Eur J Immunol (1997) 1.01

TCR reactivity in human nickel allergy indicates contacts with complementarity-determining region 3 but excludes superantigen-like recognition. J Immunol (1999) 0.98

Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur J Immunol (1997) 0.97

Network regulation among T cells; conclusions from limiting dilution experiments. Springer Semin Immunopathol (1983) 0.96

Synthetic peptides anchor T cell-specific TNP epitopes to MHC antigens. J Immunol (1992) 0.95

Cross-reactivity of T cell lines and clones to beta-lactam antibiotics. J Immunol (1996) 0.95

Peptide-conjugated hapten groups are the major antigenic determinants for trinitrophenyl-specific cytotoxic T cells. Int Immunol (1992) 0.94

T cell recognition of penicillin G: structural features determining antigenic specificity. Eur J Immunol (1996) 0.94

[On the synthesis of alpha and beta lecithins and their ether analogs]. Justus Liebigs Ann Chem (1967) 0.91

Role of hapten-anchoring peptides in defining hapten-epitopes for MHC-restricted cytotoxic T cells. Cross-reactive TNP-determinants on different peptides. J Immunol (1992) 0.90

Altered hapten ligands antagonize trinitrophenyl-specific cytotoxic T cells and block internalization of hapten-specific receptors. J Exp Med (1997) 0.89

Quantitative studies on lysolecithin-mediated hemolysis. Use of ether-deoxy lysolecithin analogs with varying aliphatic chain-lengths. Biochim Biophys Acta (1977) 0.89

Peptide immunization indicates that CD8+ T cells are the dominant effector cells in trinitrophenyl-specific contact hypersensitivity. J Invest Dermatol (2000) 0.88

Antigen-dependent and -independent IFN-gamma modulation by penicillins. J Immunol (1999) 0.87

Network regulation among T cells: qualitative and quantitative studies on suppression in the non-immune state. Immunol Rev (1984) 0.87

Analysis of major histocompatibility complex class I-restricted hapten recognition by mutation of the V-J joining of T cell receptor alpha chains. Eur J Immunol (1996) 0.86

MHC-dependent and -independent activation of human nickel-specific CD8+ cytotoxic T cells from allergic donors. J Invest Dermatol (1998) 0.86

Antigen contacts by Ni-reactive TCR: typical alphass chain cooperation versus alpha chain-dominated specificity. Int Immunol (2000) 0.86

Selective destruction of human leukemic cells by alkyl-lysophospholipids. Cancer Res (1978) 0.85

Structural complexity of antigenic determinants for class I MHC-restricted, hapten-specific T cells. Two qualitatively differing types of H-2Kb-restricted TNP epitopes. J Immunol (1993) 0.84

Quantitative studies on lysolecithin mediated hemolysis. Benzylated lysolecithin as a probe to study effects of temperature and red cell species on the hemolytic reaction. Biochim Biophys Acta (1976) 0.84

The influence of alkyl-lysophospholipids and lysophospholipid-activated macrophages on the development of metastasis of 3-Lewis lung carcinoma. Eur J Cancer (1980) 0.83

Carrier-reactive hapten-specific cytotoxic T lymphocyte clones originate from a highly preselected T cell repertoire: implications for chemical-induced self-reactivity. Eur J Immunol (1995) 0.82

Cross-reactive trinitrophenylated peptides as antigens for class II major histocompatibility complex-restricted T cells and inducers of contact sensitivity in mice. Limited T cell receptor repertoire. Eur J Immunol (1995) 0.82

Partial agonism and independent modulation of T cell receptor and CD8 in hapten-specific cytotoxic T cells. Eur J Immunol (1998) 0.82

Kinetics of CXCR4 and CCR5 up-regulation and human immunodeficiency virus expansion after antigenic stimulation of primary CD4(+) T lymphocytes. Blood (2000) 0.82

[Concerning the synthesis of lysolecithin and its ether analogs]. Justus Liebigs Ann Chem (1967) 0.82

Lysolecithin analogs as adjuvants in delayed-type hypersensitivity in mice. I. Characterization of the adjuvant effect. Eur J Immunol (1979) 0.81

Functional expression and analysis of a human HLA-DQ restricted, nickel-reactive T cell receptor in mouse hybridoma cells. J Invest Dermatol (1999) 0.81

Stabilization of detergent-solubilized Ca2+-ATPase by poly(ethylene glycol). Biochim Biophys Acta (1989) 0.81

Molecular analysis of the T-cell receptor V beta 5 and V beta 8 repertoire in pancreatic lesions of autoimmune diabetic NOD mice. J Autoimmun (1993) 0.81

[O-methylated and O-acetylated lysolecithin]. Justus Liebigs Ann Chem (1967) 0.81

Predominant T cell receptor gene elements in TNP-specific cytotoxic T cells. J Immunol (1991) 0.81

Selective activation of CD8 T cell effector functions by epitope variants of lymphocytic choriomeningitis virus glycoprotein. J Immunol (1996) 0.81

Carrier-independent hapten recognition and promiscuous MHC restriction by CD4 T cells induced by trinitrophenylated peptides. J Immunol (1997) 0.80

Spontaneous and detergent-induced vesiculation of thymocyte plasma membranes. Biochim Biophys Acta (1980) 0.80

Increased frequency of 2,4,6-trinitrophenyl (TNP)-specific, H-2b-restricted cytotoxic T lymphocyte precursors in transgenic mice expressing a T cell receptor beta chain gene from an H-2b-restricted, TNP-specific cytolytic T cell clone. Eur J Immunol (1992) 0.79

[On the structure-dependent hemolytic activity of some choline phosphatides]. Z Naturforsch B (1968) 0.79

Alkyl-lysophospholipid induced suppression of human lymphocyte response to mitogens and selective killing of lymphoblasts. Immunobiology (1980) 0.79

Slow-reacting hemolytic phosphatides: benzylated lysolecithins. Biochim Biophys Acta (1973) 0.78

Detergent properties of water-soluble choline phosphatides. Selective solubilization of acyl-CoA:lysolecithin acyltransferase from thymocyte plasma membranes. J Biol Chem (1979) 0.78

Effect of lysolecithin and analogs on mouse ascites tumors. Cancer Res (1978) 0.78

Purified MHC class I molecules present hapten-conjugated peptides to TNP/H-2Kb-specific T cell hybridomas. Immunol Lett (1993) 0.78

Involvement of the T cell antigen receptor and of Lyt-2 in the cytotoxic function of aged killer (AK) T cells. J Exp Med (1986) 0.77

Distribution and metabolism of synthetic alkyl analogs of lysophosphatidylcholine in mice. Biochim Biophys Acta (1978) 0.77

Clonal anergy induced in a CD8+ hapten-specific cytotoxic T-cell clone by an altered hapten-peptide ligand. Immunology (2001) 0.77

Effects of a synthetic lysolecithin analog on the phase transition of mixtures of phosphatidylethanolamine and phosphatidylcholine. FEBS Lett (1976) 0.76

Intracellular processing of hapten-modified protein for MHC class I presentation: cytoplasmic delivery by pH-sensitive liposomes. Immunol Lett (1993) 0.75

Acidic "peptidophospholipids", a new class of hapten-bearing cell surface modifying reagents. Mol Immunol (1984) 0.75

Hapten-specific cytotoxic T cell clones undergo somatic variation of their antigen recognition specificity. Eur J Immunol (1986) 0.75

Relation of cytolytic activity of an ether-deoxy lysophosphatidylcholine analog to available membrane surface. Comparison of normal and tumor cells from mice. Biochim Biophys Acta (1978) 0.75

Molecular aggregation of the slow reacting hemolytic lysolecithin analog 1-octadecyl-2-benzyl-glycero-3-phosphorylcholine in aqueous solution. Chem Phys Lipids (1976) 0.75

Loss of antigen recognition and impaired cytolytic function in most hybrids between cytotoxic T cells and BW5147. Scand J Immunol (1987) 0.75

Lysolecithin induced membrane alterations in thymocytes. Effects of lysophosphatides possessing adjuvant and immuno-suppressive activities on cell agglutination by concanavalin A. Z Naturforsch C (1976) 0.75

Proceedings: Interaction of lysolecithin analogs with various hydrophobicities with erythrocyte membranes. Hoppe Seylers Z Physiol Chem (1974) 0.75

Further characterization of UVB radiation effects on Langerhans cells: altered expression of the costimulatory molecules B7-1 and B7-2. Photochem Photobiol (1998) 0.75

Somatic variation of antigen-recognition specificity in H-2b-TNP-specific cytotoxic T-cell clones. Curr Top Microbiol Immunol (1986) 0.75

Intercellular communication between lymphocytes in vitro. Fluorescein-permeable junctions, their enhancement by lysolecithin and their reduction by a synthetic immunosuppressive lysolecithin analogue. Eur J Immunol (1974) 0.75

Effects of lysolecithin and synthetic analogs on Concanavalin A induced agglutination of chicken, human and bovine erythrocytes. Exp Cell Res (1975) 0.75